The Road to First-in-Human Trials: Insights from a Real-World Example
Watch On Demand
The journey to the first-in-human clinical trial for a drug project has many potential bumps and detours. Together with our friends at Dicot AB, we’ll discuss and give their real-world examples of the success factors of the journey towards a first-in-human study on their drug candidate, LIB-01. We’ll discuss the prerequisites for keeping project plans, delivery of results and dealing with the consequences of decisions made during the drug development.
By attending this webinar, you'll be better equipped to make your journey to clinical trials smoother – this is a must for C-level managers, project managers, scientists and regulatory experts.
What you'll learn:
- Mapping the Route: Understanding the drug development process
- Route Planning: Making informed decisions
- Avoiding Detours: Pro-actively ensuring adherence to regulatory guidelines for your specific drug development project
- End of the initial Journey: Arriving at clinical trials and planning for the next phase
Register to watch the webinar to unravel the potential of your pre-clinical programme.
Meet the Speakers:
-
Ulrika Andersson, Director Drug Development, Cytel
-
Anna Sandholm, Senior Consultant DMPK & Clinical Pharmacology, Cytel
-
Jonas Ahlbom, Senior Consultant toxicology, Cytel
-
Bodil Fornstedt Wallin, Senior Consultant Clinical Development, Cytel
-
Bengt Hedin, Senior Consultant CMC, Cytel
- Nina Knave, Senior Consultant Clinical Project Management, Cytel
- Charlotta Gauffin, Chief Scientific Officer, Dicot
